Aptorum Group Ltd-Class A

Penny Stocks Biotech Stocks Healthcare Stocks

$0.79

+0.02 (+1.98%)

As of Jun 30, 4:50 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 5 83%

Hold 1 17%

Sell 0 0%

Price Target

Analyst Price Target +1,471.3% upside

Low Target $9.33

Average Target $12.39

High Target $15.15

Current Price $0.79

Current
$0.79

Target
$12.39

$9.33 $12.39 avg $15.15

Scenario Analysis

Bear Case

$9.33

1,083.3%

Low target

Base Case

$12.39

+1,471.3%

Avg target

Bull Case

$15.15

+1,821.4%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$4.47

-82.4% from high

52-Week Low

$0.65

+21.3% from low

Target vs 52W High

$12.39

+177.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%